CA21154 - Translational control in Cancer European Network (TRANSLACORE)
TRANSLACORE
Understanding the importance of protein synthesis dysregulation in cancer
CA21154 - Translational control in Cancer European Network (TRANSLACORE)
Translacore
Join the Network
CA21154 - Translational control in Cancer European Network (TRANSLACORE)
Map of TRANSLACORE Team Members Across Europe
Our aims
Philosophy
Understanding the importance of protein synthesis dysregulation in cancer
Objectives
Promoting multiple cross-disciplinary research partnerships
Capacity Building
Strengthen scientific interactions among experts across Europe with complementary skills
State of the art
Dysregulated translation in cancer exposes vulnerabilities that are amenable to targeted therapies.
People involved in Translacore
View all members
You might also like
Translacore open database
Grant for a Short-Term Scientific Mission
As the 4th year of TRANSLACORE has now started, we are pleased to launch the 1st Call of Short-Term Scientific Mission (STSM).
Diet boosts drug effect against neuroblastoma
A new Nature study by member of the TRANSLACORE society - Raphael J. Morscher and colleagues reveals that combining a specific diet with the drug difluoromethylornithine can significantly slow neuroblastoma growth. By restricting the amino acids arginine and proline, researchers reduced polyamine production, molecules that fuel tumour growth. This dual approach disrupted cancer protein synthesis, and improved survival. The findings highlight how diet can be harnessed to reprogram aggressive childhood cancers toward remission.
Second edition - Biennale 2025
The Biennale 2025 marks the successful continuation and expansion of the groundbreaking 2023 edition, where science and art first joined to form a powerful platform for interdisciplinary dialogue. This year’s theme, Cycle of Health and Cancer, builds on past achievements by deepening public understanding and scientific exploration of the biological processes that govern health, disease, and recovery.
